Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 201–300 of 1,000
Zhang, M., Schulte, J. S., Heinick, A., Piccini, I., Rao, J., Quaranta, R., Zeuschner, D., Malan, D., Kim, K.-P., Röpke, A., et al. (2015) · Stem Cells · doi:10.1002/stem.1964 · Cited by 95
Interplay of cell–cell contacts and RhoA/ MRTF ‐A signaling regulates cardiomyocyte identity
Dorn, T., Kornherr, J., Parrotta, E. I., Zawada, D., Ayetey, H., Santamaria, G., Iop, L., Mastantuono, E., Sinnecker, D., Goedel, A., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798133 · Cited by 88
Self-citationShinnawi, R., Shaheen, N., Huber, I., Shiti, A., Arbel, G., Gepstein, A., Ballan, N., Setter, N., Tijsen, A. J., Borggrefe, M. M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.055 · Cited by 92
Oikonomopoulos, A., Kitani, T., & Wu, J. C. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.026 · Cited by 94
Yang, K.-C., Breitbart, A., De Lange, W. J., Hofsteen, P., Futakuchi-Tsuchida, A., Xu, J., Schopf, C., Razumova, M. V., Jiao, A., Boucek, R., et al. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2018.08.008 · Cited by 93
Schwartz, P. J., Gnecchi, M., Dagradi, F., Castelletti, S., Parati, G., Spazzolini, C., Sala, L., & Crotti, L. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz023 · Cited by 89
Three-dimensional cardiac tissue fabrication based on cell sheet technology
Masuda, S., & Shimizu, T. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.002 · Cited by 92
Frank, S., Zhang, M., Schöler, H. R., & Greber, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041958 · Cited by 87
Parrotta, E. I., Lucchino, V., Scaramuzzino, L., Scalise, S., & Cuda, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124354 · Cited by 88
Sala, L., Yu, Z., Ward‐van Oostwaard, D., van Veldhoven, J. P., Moretti, A., Laugwitz, K., Mummery, C. L., IJzerman, A. P., & Bellin, M. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606260 · Cited by 87
Self-citationSuppression-Replacement KCNQ1 Gene Therapy for Type 1 Long QT Syndrome
Dotzler, S. M., Kim, C. S. J., Gendron, W. A. C., Zhou, W., Ye, D., Bos, J. M., Tester, D. J., Barry, M. A., & Ackerman, M. J. (2021) · Circulation · doi:10.1161/circulationaha.120.051836 · Cited by 95
Engineered Microenvironments for Maturation of Stem Cell Derived Cardiac Myocytes
Besser, R. R., Ishahak, M., Mayo, V., Carbonero, D., Claure, I., & Agarwal, A. (2017) · Theranostics · doi:10.7150/thno.19441 · Cited by 94
Veerman, C. C., Mengarelli, I., Lodder, E. M., Kosmidis, G., Bellin, M., Zhang, M., Dittmann, S., Guan, K., Wilde, A. A. M., Schulze‐Bahr, E., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005135 · Cited by 86
Self-citationKadota, S., Minami, I., Morone, N., Heuser, J. E., Agladze, K., & Nakatsuji, N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs418 · Cited by 82
Repolarization Heterogeneity: Beyond the QT Interval
Prenner, S. B., Shah, S. J., Goldberger, J. J., & Sauer, A. J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003607 · Cited by 90
Chen, Z., Xian, W., Bellin, M., Dorn, T., Tian, X. Y., Goedel, A., Dreizehnter, L., Poch, C. M., Oostwaard, D. W., Ng, J. K. M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw189 · Cited by 85
Self-citationFatima, A., Kaifeng, S., Dittmann, S., Xu, G., Gupta, M. K., Linke, M., Zechner, U., Nguemo, F., Milting, H., Farr, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083005 · Cited by 83
Tiscórnia, G., Lorenzo-Vivas, E., Matalonga, L., Berniakovich, I., Barragán, M., Eguizábal, C., Gort, L., Gonzãlez, F., Mellet, C. O., Fernández, J. M. G., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds471 · Cited by 92
Automated analysis of contractile force and Ca2+transients in engineered heart tissue
Stoehr, A., Neuber, C., Baldauf, C., Vollert, I., Friedrich, F. W., Flenner, F., Carrier, L., Eder, A., Schaaf, S., Hirt, M. N., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00705.2013 · Cited by 83
“was reprogrammed with lenti/retroviral vectors and characterized for pluripotency (21).”
BackgroundSelf-citationLife in the Fast Lane: Mammalian Disease Models in the Genomics Era
Dow, L. E., & Lowe, S. W. (2012) · Cell · doi:10.1016/j.cell.2012.02.023 · Cited by 90
Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes
Li, W., Wang, X., Fan, W., Zhao, P., Chan, Y.-C., Chen, S., Zhang, S., Guo, X., Zhang, Y., Li, Y., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr435 · Cited by 80
Eschenhagen, T., & Carrier, L. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2214-0 · Cited by 86
Developmental and Regenerative Biology of Multipotent Cardiovascular Progenitor Cells
Sturzu, A. C., & Wu, S. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.227066 · Cited by 90
Induced pluripotent stem cells for modelling human diseases
Unternaehrer, J. J., & Daley, G. Q. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0017 · Cited by 80
Human iPSC modeling of heart disease for drug development
Hnatiuk, A. P., Briganti, F., Staudt, D., & Mercola, M. A. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.016 · Cited by 82
Honda, M., Kiyokawa, J., Tabo, M., & Inoue, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11038fp · Cited by 89
Veerman, C. C., Mengarelli, I., Guan, K., Stauske, M., Barc, J., Tan, H. L., Wilde, A. A. M., Verkerk, A. O., & Bezzina, C. R. (2016) · Scientific Reports · doi:10.1038/srep30967 · Cited by 81
Clinical potentials of human pluripotent stem cells
Mora, C., Serzanti, M., Consiglio, A., Memo, M., & Dell’Era, P. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9384-y · Cited by 85
Zhao, Z., Lan, H., El‐Battrawy, I., Li, X., Buljubasic, F., Sattler, K., Yücel, G., Lang, S., Tiburcy, M., Zimmermann, W., et al. (2018) · Stem Cells International · doi:10.1155/2018/6067096 · Cited by 87
Scheel, O., Frech, S., Amuzescu, B., Eisfeld, J., Lin, K.-H., & Knott, T. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2014.601 · Cited by 78
Tissue Engineering the Vascular Tree
Traoré, M. A., & George, S. C. (2017) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2017.0010 · Cited by 92
Zwi-Dantsis, L., Huber, I., Habib, M., Winterstern, A., Gepstein, A., Arbel, G., & Gepstein, L. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs096 · Cited by 78
Mandenius, C., Steel, D. M., Noor, F., Meyer, T. S., Heinzle, E., Asp, J., Arain, S., Kraushaar, U., Bremer, S., Class, R., et al. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1663 · Cited by 89
Casini, S., Verkerk, A. O., & Remme, C. A. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6735-0 · Cited by 83
Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities
Hajipour, M. J., Mehrani, M., Abbasi, S. H., Amin, A., Kassaian, S. E., Garbern, J. C., Caracciolo, G., Zanganeh, S., Chitsazan, M., Aghaverdi, H., et al. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00323 · Cited by 79
Using human induced pluripotent stem cells to treat retinal disease
Borooah, S., Phillips, M. J., Bilican, B., Wright, A. F., Wilmut, I., Chandran, S., Gamm, D. M., & Dhillon, B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.09.002 · Cited by 81
Shaheen, N., Shiti, A., Huber, I., Shinnawi, R., Arbel, G., Gepstein, A., Setter, N., Goldfracht, I., Gruber, A., Chorna, S. V., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.04.006 · Cited by 75
Devalla, H. D., & Passier, R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5457 · Cited by 75
Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models
Dambrot, C., Passier, R. C., Atsma, D. E., & Mummery, C. L. (2011) · Biochemical Journal · doi:10.1042/bj20101707 · Cited by 82
Paci, M., Pölönen, R.-P., Cori, D., Penttinen, K., Aalto‐Setälä, K., Severi, S., & Hyttinen, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00709 · Cited by 77
Ebert, A., Joshi, A. U., Andorf, S., Dai, Y., Sampathkumar, S., Chen, H., Li, Y., Garg, P., Toischer, K., Hasenfuss, G. P., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313973 · Cited by 75
Sallam, K., Li, Y., Sager, P. T., Houser, S. R., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.116.304494 · Cited by 74
Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery
Tani, H., & Tohyama, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.855763 · Cited by 83
Kinnear, C., Chang, W. Y., Khattak, S., Hinek, A., Thompson, T., Rodrigues, D. C., Kennedy, K., Mahmut, N., Pasceri, P., Stanford, W. L., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0054 · Cited by 79
El‐Battrawy, I., Zhao, Z., Lan, H., Schünemann, J.-D., Sattler, K., Buljubasic, F., Patocskai, B., Li, X., Yücel, G., Lang, S., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.007 · Cited by 73
Stöhr, A., Friedrich, F. W., Flenner, F., Geertz, B., Eder, A., Schaaf, S., Hirt, M. N., Uebeler, J., Schlossarek, S., Carrier, L., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.011 · Cited by 72
Benzoni, P., Campostrini, G., Landi, S., Bertini, V., Marchina, E., Iascone, M. R., Ahlberg, G., OLESEN, M. S., Crescini, E., Mora, C., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz217 · Cited by 76
p53-Facilitated miR-199a-3p Regulates Somatic Cell Reprogramming
Wang, J., He, Q., Han, C., Gu, H., Jin, L., Li, Q., Mei, Y., & Wu, M. (2012) · Stem Cells · doi:10.1002/stem.1121 · Cited by 75
Human pluripotent stem cells for disease modelling and drug screening
Maury, Y., Gauthier, M., Peschanski, M., & Martinat, C. (2011) · BioEssays · doi:10.1002/bies.201100071 · Cited by 76
Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering
Montero, P., Flandes‐Iparraguirre, M., Musquiz, S., Pérez-Araluce, M., Plano, D., Sanmartín, C., Orive, G., Gavira, J. J., Prósper, F., & Mazo, M. M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00955 · Cited by 74
Salani, S., Donadoni, C., Rizzo, F., Bresolin, N., Comi, G. P., & Corti, S. P. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01498.x · Cited by 77
Sharma, A., Wu, J. C., & Wu, S. M. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt380 · Cited by 76
Mazzola, M., & Pasquale, E. D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00455 · Cited by 78
SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development
Skelton, R. J. P., Costa, M., Anderson, D. J., Bruveris, F., Finnin, B. W., Koutsis, K., Arasaratnam, D., White, A. J., Rafii, A., Ng, E., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.04.016 · Cited by 79
Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
Narsinh, K., Narsinh, K. H., & Wu, J. C. (2011) · Circulation Research · doi:10.1161/circresaha.111.240374 · Cited by 73
Dambrot, C., Braam, S. R., Tertoolen, L. G. J., Birket, M. J., Atsma, D. E., & Mummery, C. L. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12356 · Cited by 78
Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
Acimovic, I., Vilotic, A., Pesl, M., Lacampagne, A., Dvorak, P., Rotrekl, V., & Meli, A. C. (2014) · BioMed Research International · doi:10.1155/2014/512831 · Cited by 66
Huang, H., Pugsley, M. K., Fermini, B., Curtis, M. J., Koerner, J. E., Accardi, M. V., & Authier, S. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.04.002 · Cited by 78
Kane, C., & Terracciano, C. M. N. (2017) · Stem Cells · doi:10.1002/stem.2649 · Cited by 64
Physiological genomics identifies genetic modifiers of long QT syndrome type 2 severity
Chai, S., Wan, X., Ramirez-Navarro, A., Tesar, P. J., Kaufman, E. S., Ficker, E., George, A. L., & Deschênes, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94996 · Cited by 67
Reilly, L., & Eckhardt, L. L. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.04.008 · Cited by 69
Hayakawa, T., Kunihiro, T., Dowaki, S., Uno, H., Matsui, E., Uchida, M., Kobayashi, S., Yasuda, A., Shimizu, T., & Okano, T. (2012) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2011.0273 · Cited by 68
Baldassarre, A. D., Cimetta, E., Bollini, S., Gaggi, G., & Ghinassi, B. (2018) · Cells · doi:10.3390/cells7060048 · Cited by 78
The mesenchymal-to-epithelial transition in somatic cell reprogramming
Esteban, M. A., Bao, X., Zhuang, Q., Zhou, T., Qin, B., & Pei, D. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.09.004 · Cited by 74
Krane, M., Dreßen, M., Santamaria, G., My, I., Schneider, C. M., Dorn, T., Laue, S., Mastantuono, E., Berutti, R., Rawat, H., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056198 · Cited by 69
Self-citationSafety pharmacology — Current and emerging concepts
Hamdam, J. M., Sethu, S., Smith, T., Alfirevic, A., Alhaidari, M., Atkinson, J., Ayala, M., Box, H., Cross, M. J., Delaunois, A. G., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.039 · Cited by 75
Cardiac Sodium Channel Nav1.5 Mutations and Cardiac Arrhythmia
Song, W., & Shou, W. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0303-y · Cited by 68
Cordeiro, J. M., Nesterenko, V. V., Sicouri, S., Goodrow, R. J., Treat, J. A., Desai, M., Wu, Y., Doss, M. X., Antzelevitch, C. N., & Diego, J. M. D. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.014 · Cited by 75
Sasaki, K., Makiyama, T., Yoshida, Y., Wuriyanghai, Y., Kamakura, T., Nishiuchi, S., Hayano, M., Harita, T., Yamamoto, Y., Kohjitani, H., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164795 · Cited by 65
Induced pluripotent stem cell–derived cardiomyocytes in studies of inherited arrhythmias
Priori, S. G., Napolitano, C., Di Pasquale, E., & Condorelli, G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62838 · Cited by 65
Blazeski, A., Zhu, R., Hunter, D. W., Weinberg, S. H., Zambidis, E. T., & Tung, L. (2012) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2012.07.013 · Cited by 66
The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening
Khan, J. M., Lyon, A. R., & Harding, S. E. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02118.x · Cited by 63
Common variation in atrial fibrillation: navigating the path from genetic association to mechanism
Tucker, N. R., Clauß, S., & Ellinor, P. T. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvv283 · Cited by 71
van Mil, A., Balk, G. M., Neef, K., Buikema, J. W., Asselbergs, F. W., Wu, S. M., Doevendans, P. A., & Sluijter, J. P. G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy208 · Cited by 65
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
Nicholson, M. W., Ting, C.-Y., Chan, D. Z. H., Cheng, Y.-C., Lee, Y.-C., Hsu, C.-C., Huang, C.-Y., & Hsieh, P. C. H. (2022) · Cells · doi:10.3390/cells11111853 · Cited by 65
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
BackgroundResultInfluentialRoost, M. S., Slieker, R. C., Bialecka, M., van Iperen, L., Gomes Fernandes, M. M., He, N., Suchiman, H. E. D., Szuhai, K., Carlotti, F., de Koning, E. J. P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01077-3 · Cited by 65
Huang, J., Zhou, S., Niu, X., Hu, B., Li, Q., Zhang, F., Zhang, X., Cai, X., Lou, Y., Liu, F., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0645-8 · Cited by 65
Using iPS Cells toward the Understanding of Parkinson’s Disease
Torrent, R., De Angelis Rigotti, F., Dell'Era, P., Memo, M., Raya, A., & Consiglio, A. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4040548 · Cited by 60
Pahnke, A., Conant, G., Huyer, L. D., Zhao, Y., Feric, N. T., & Radisic, M. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.060 · Cited by 64
Chang, Y.-L., Chen, S., Kao, C.-L., Hung, S., Ding, D., Yu, C.-C., Chen, Y., Ku, H., Lin, C.-P., Lee, K.-H., et al. (2011) · Cell Transplantation · doi:10.3727/096368911x580572 · Cited by 65
Motta, B. M., Pramstaller, P. P., Hicks, A. A., & Rossini, A. (2017) · Stem Cells International · doi:10.1155/2017/8960236 · Cited by 67
Fuerstenau-Sharp, M., Zimmermann, M. E., Stark, K. J., Jentsch, N., Klingenstein, M., Drzymalski, M. A., Wagner, S., Maier, L. S., Hehr, U., Baessler, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126596 · Cited by 67
iPSC technology-Powerful hand for disease modeling and therapeutic screen
Kim, C. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.5.100 · Cited by 70
Guo, F., Sun, Y., Wang, X., Wang, H., Wang, J., Gong, T., Chen, X., Zhang, P., Su, L., Fu, G., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313518 · Cited by 63
The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications
Youssef, A. A., Ross, E. G., Bolli, R., Pepine, C. J., Leeper, N. J., & Yang, P. C. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.06.010 · Cited by 50
Schweitzer, M. K., Wilting, F., Sedej, S., Dreizehnter, L., Dupper, N. J., Tian, X. Y., Moretti, A., My, I., Kwon, O., Priori, S. G., et al. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.06.008 · Cited by 67
Self-citationUse of stem cells as alternative methods to animal experimentation in predictive toxicology
Kim, T., Che, J., & Yun, J.-W. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.03.016 · Cited by 63
Kamdar, F. D., Das, S., Gong, W., Kamdar, A. K., Vetter, T. A., Shah, P., Ervasti, J. M., Townsend, D., Kamp, T. J., Wu, J. C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.066 · Cited by 64
Odening, K. E., Gomez, A. M., Dobrev, D., Fabritz, L., Heinzel, F. R., Mangoni, M. E., Molina, C. E., Sacconi, L., Smith, G. L., Štengl, M., et al. (2021) · EP Europace · doi:10.1093/europace/euab142 · Cited by 68
Paci, M., Hyttinen, J., Rodríguez, B., & Severi, S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13282 · Cited by 70
Huo, J., Kamalakar, A., Yang, X., Word, B. R., Stockbridge, N., Lyn‐Cook, B. D., & Pang, L. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw235 · Cited by 61
Paci, M., Passini, E., Severi, S., Hyttinen, J., & Rodríguez, B. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.07.026 · Cited by 63
Yap, L., Wang, J., Moreno‐Moral, A., Chong, L. Y., Sun, Y., Harmston, N., Wang, X., Chong, S. Y., Vanezis, K., Öhman, M. K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.083 · Cited by 63
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60
Self-citationZhang, H., Zou, B., Yu, H., Moretti, A., Wang, X., Yan, W., Babcock, J. J., Bellin, M., McManus, O. B., Tomaselli, G. F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205266109 · Cited by 60
Self-citationMartins, A. M., Vunjak-Novakovic, G., & Reis, R. L. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9487-7 · Cited by 59
Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
Oh, Y., Wei, H., Ma, D., Sun, X., & Liew, R. (2012) · Heart · doi:10.1136/heartjnl-2011-301317 · Cited by 64
Detection of genetic cardiac diseases by Ca2+ transient profiles using machine learning methods
Juhola, M., Joutsijoki, H., Penttinen, K., & Aalto‐Setälä, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-27695-5 · Cited by 61
Kurokawa, Y. K., & George, S. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.004 · Cited by 59
Stem Cell-Derived Systems in Toxicology Assessment
Suter-Dick, L., Alves, P. M., Blaauboer, B. J., Bremm, K.-D., Brito, C., Coecke, S., Flick, B., Fowler, P., Hescheler, J., Ingelman-Sundberg, M., et al. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0540 · Cited by 56
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.